We are live on ! Find out more
BTEC

Principal Exchange-Traded Funds Principal Healthcare Innovators ETF

Delisted

BTEC was delisted on the 31st of July, 2024.

24 hedge funds and large institutions have $34.5M invested in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 11 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

13% more capital invested

Capital invested by funds: $30.6M → $34.5M (+$3.89M)

4% more funds holding

Funds holding: 2324 (+1)

73% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 11

Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
11
Closed
1
Calls
Puts
Net Calls
Net Calls Change

BTEC Hedge Fund Activity: Q4 2023 in Review

24 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) for Q4 2023, worth a combined $34.5M — up 13% from $30.6M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new BTEC positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 11 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $318K. The largest seller was Royal Bank of Canada, cutting an estimated $1.52M.

  • 24 institutional investors held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) as of Q4 2023, up from 23 in Q3 2023.
  • Funds reported $34.5M of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF stock for Q4 2023, up 13% quarter-over-quarter.
  • 2 funds opened new Principal Exchange-Traded Funds Principal Healthcare Innovators ETF positions in Q4 2023 and 1 closed out, a net change of +1 holder.
  • The largest Principal Exchange-Traded Funds Principal Healthcare Innovators ETF buyer in Q4 2023 was Morgan Stanley, an estimated $318K added.
  • The largest Principal Exchange-Traded Funds Principal Healthcare Innovators ETF seller in Q4 2023 was Royal Bank of Canada, an estimated $1.52M sold.

Based on aggregated 13F filings for Q4 2023.